BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 25716682)

  • 1. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
    Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
    Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
    Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
    Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
    Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
    Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
    Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR
    Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
    De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
    Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
    Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
    Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
    Wang J; Wang X; Liu F; Fu Y
    Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial-mesenchymal transition.
    Su Q; Shen H; Gu B; Zhu N
    Bioengineered; 2021 Dec; 12(1):9058-9069. PubMed ID: 34698000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ATB promotes the epithelial-mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer.
    Li RH; Chen M; Liu J; Shao CC; Guo CP; Wei XL; Li YC; Huang WH; Zhang GJ
    Cell Death Dis; 2018 Dec; 9(12):1171. PubMed ID: 30518916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer.
    Zhan Y; Li X; Liang X; Li L; Cao B; Wang B; Ma J; Ding F; Wang X; Pang D; Liu Z
    Oncotarget; 2017 Jan; 8(3):4629-4641. PubMed ID: 27894095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.
    Liu S; Cui J; Liao G; Zhang Y; Ye K; Lu T; Qi J; Wan G
    Tumour Biol; 2014 Sep; 35(9):9131-8. PubMed ID: 25027394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
    Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
    Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
    Liu W; Zhang B; Xu N; Wang MJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
    Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
    Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.